Table 1. Participant Characteristics by Treatment Group.
Demographics and tumor characteristics for patients in each treatment group.
| Neoadjuvant Chemo % (n = 27) | Surgery/ Chemo % (n = 156) | Surgery/ Radiation % (n = 30) | Surgery/Radiation/ Chemo % (n = 47) | p | |
|---|---|---|---|---|---|
|
| |||||
| Age | 0.279 | ||||
| Median (Range) | 66.3 (46–81) | 63.2 (30–82) | 65.5 (38–88) | 60.0 (40–78) | |
|
| |||||
| Race | 0.008 | ||||
| White | 29.6 (8) | 71.2 (111) | 76.7 (23) | 72.3 (34) | |
| African-American | 48.2 (13) | 16.7 (26) | 13.3 (4) | 12.8 (6) | |
| Hispanic | 14.8 (4) | 6.4 (10) | 10 (3) | 8.5 (4) | |
| Asian | 7.4 (2) | 5.1 (8) | 0 (0) | 6.4 (3) | |
| Other | 0 (0) | 0.6 (1) | 0 (0) | 0 (0) | |
|
| |||||
| BMI | 0.216 | ||||
| Median (Range) | 29.2 (18.1–68.8) | 29.6 (17.5–105) | 26.1 (18.7–39.9) | 29.6 (17.8–45) | |
|
| |||||
| Stage | <0.001 | ||||
| IIIA | 0 (0) | 6.4 (10) | 13.3 (4) | 19.2 (9) | |
| IIIB | 0 (0) | 1.3 (2) | 0 (0) | 8.5 (4) | |
| IIIC1 | 0 (0) | 14.7 (23) | 40 (12) | 36.2 (17) | |
| IIIC2 | 0 (0) | 21.2 (33) | 30 (9) | 27.7 (13) | |
| IVA | 7.4 (2) | 1.9 (3) | 0 (0) | 0 (0) | |
| IVB | 81.5 (22) | 54.5 (85) | 16.7 (5) | 8.5 (4) | |
| Unstaged | 11.1 (3) | 0 (0) | 0 (0) | 0 (0) | |
|
| |||||
| Histology | 0.002 | ||||
| Pure USC | 70.4 (19) | 36.5 (57) | 23.3 (7) | 31.9 (15) | |
| Mixed | 29.6 (8) | 63.5 (99) | 76.7 (23) | 68.1 (32) | |